Status:
COMPLETED
Hemodialysis and Erythrocyte Fatty-Acid Status: a Lipidomics Study
Lead Sponsor:
Benjamin Gollasch
Conditions:
Fatty Acid Metabolism
Erythrocytes
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Hypotension with potentially serious consequences for organ perfusion is a common complication in extracorporeal procedures such as hemodialysis / hemofiltration. The exact reasons for this are still ...
Detailed Description
Differences in Erythrocyte Fatty-Acid Status Profiling in: * before and after hemodialysis intervention * in hemodialysis patients and healthy individuals Venous blood will be collected from each sub...
Eligibility Criteria
Inclusion
- Inclusion Criteria for hemodialysis patients:
- Patients who have a history of renal failure and undergo hemodialysis / hemofiltration
- Age over 18 years
- Ability to consent
- There is a written consent of the study participant
- Exclusion Criteria for healthy control group:
- chronic illness requiring any medication
- pregnancy
- limitations regarding functioning in the hypoxic chamber
- inability to follow simple instructions relevant or severe abnormalities in medical history, physical examination
Exclusion
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03857984
Start Date
May 1 2018
End Date
February 1 2022
Last Update
March 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité University Experimental & Clinical Research Center
Berlin, Germany, 13125